Zusammenfassung
Die Kleptomanie wird entsprechend weit verbreiteter Klassifikationssysteme wie ICD-10 und DSM-IV zu den Impulskontrollstörungen gerechnet. Insbesondere unter Berücksichtigung der Komorbidität ergibt sich, dass die Kleptomanie zum Spektrum zwanghafter Störungen (obsessive-compulsive disorder-spectrum) und zum umfassenderen Spektrum affektiver Störungen assoziiert ist. Daraus leitet sich dann eine psychopharmakologische Interventionsmöglichkeit mit Antidepressiva oder stimmungsstabilisierenden Medikamenten ab, für welche keine Ergebnisse von Therapiestudien vorliegen, über deren erfolgreichen Einsatz jedoch kasuistische Mitteilungen gegeben wurden. Unter der Voraussetzung einer gestörten zentralen Serotonintransmission scheint sich dabei insbesondere der Einsatz von Serotoninwiederaufnahmehemmer (SSRI) zu bewähren. Eine Therapiealternative scheint jedoch in der Anwendung von Naltrexon zu bestehen.
Abstract
According to most diagnostic manuals such as ICD-10 and DSM-IV, kleptomania is classified as an impulse-control disorder. With regard to comorbidity, kleptomania is related to the obsessive- compulsive disorder spectrum and to the broarder spectrum of affective disorders. Accordingly a psychopharmalogical intervention with anti-depressant drugs or mood stabilizers may be possible, even though there are to date no known results from controlled therapy studies. Nevertheless the successful administration of such medication has been reported in several cases. Assuming a disturbed central serotonin reuptake, the use of selective serotonin reuptake inhibitors (SSRI) seems to be indicated. But also naltrexone could be of use in kleptomania.
Literatur
-
1
Dannon P N.
Kleptomania: an impulse control disorder?.
Int J Psych Clin Pract.
2002;
6
3-7
-
2
Gertz H J, Müller U.
Ein Fall von Kleptomanie.
Psychiat Prax.
2002;
29
101-103
-
3
Goldman M J.
Kleptomania: making sense of the nonsensical.
Am J Psychiatry.
1991;
148
986-996
-
4
Goldman M J.
Kleptomania: an overview.
Psychiatric Annals.
1992;
22
68-71
-
5
Sarasalo E, Bergman B, Toth J.
Personality traits and psychiatric and somatic morbidity among kleptomaniacs.
Acta Psychiatr Scand.
1996;
94
358-364
-
6
Mc Elroy S, Pope H G, Hudson J I, Keck P E, White K L.
Kleptomania: a report of 20 cases.
Am J Psychiatry.
1991;
148
652-657
-
7
Mc Elroy S, Keck P E, Phillips K A.
Kleptomania, compulsive buying and binge-eating disorder.
J Clin Psychiatry.
1995;
56 (suppl 4)
14-26
-
8
Lejoyeux M, Mc Loughlin M, Adès J.
Epidemiology of behavioral dependence: literature review and results of original studies.
Eur Psychiatry.
2000;
15
129-134
-
9
Mc Elroy S, Hudson J I, Pope H G, Keck P E.
Kleptomania: clinical characteristics and associated psychopathology.
Psychological Medicine.
1991;
21
93-108
-
10
Hudson J I, Pope H G.
Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?.
Am J Psychiatry.
1990;
147
552-564
-
11
Mc Elroy S, Hudson J I, Pope H G, Keck P E, Aizley H G.
The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders.
Am J Psychiatry.
1992;
149
318-327
-
12
Mc Elroy S, Pope H G, Keck P E, Hudson J I, Phillips K A, Strakowski S M.
Are impulse-control disorders related to bipolar disorder?.
Comprehensive Psychiatry.
1996;
37 (4)
229-240
-
13
Hollander E, Wong C M.
Obsessive-compulsive spectrum disorders.
J Clin Psychiatry.
1995;
56 (suppl 4)
3-6
-
14
Hollander E, Rosen J.
Impulsivity.
Journal of Psychopharmacology.
2000;
14 (2) (suppl 1)
39-44
-
15
Joseph R.
Frontal lobe psychopathology: Mania, depression, confabulation, catatonia, perseveration, obsessive compulsions and schizophrenia.
Psychiatry.
1999;
62
138-172
-
16
Kozian R.
Kleptomanie bei Frontalhirnläsion.
Psychiat Prax.
2001;
28
98-99
-
17
Gössling H W, Rosin J.
Kleptomanie vor und nach einer spontanen Subarachnoidalblutung - Ein neuropsychodynamischer Fall.
Fortschr Neurol Psychiat.
1994;
62
164-168
-
18
Khan K, Martin I CA.
Kleptomania as a presenting feature of cortical atrophy.
Acta psychiat scand.
1977;
56
168-172
-
19
Nyffeler T, Regard M.
Kleptomania in a patient with a right frontolimbic lesion.
Neuropsychiatry Neuropsychol Behav Neurol.
2001;
14
73-76
-
20
Evenden J.
Impulsivity: a discussion of clinical and experimental findings.
J Psychopharmacol.
1999;
13
180-192
-
21
Kim S W.
Opioid antagonists in the treatment of impulse-control disorders.
J Clin Psychiatry.
1998;
59
159-164
-
22
Volkow N D, Fowler J S, Wolf A P. et al .
Changes in brain glucose metabolism in cocaine dependence and withdrawal.
Am J Psychiatry.
1991;
148
621-626
-
23
Ho M Y, Al-Zahrani S SA, Al-Ruwaitea A SA, Bradshaw C M, Szabadi E.
5-Hydroxytryptamine and impulse control: prospects for a behavioural analysis.
Journal of Psychopharmacology.
1998;
12 (1)
68-78
-
24
Marazziti D, Dell'Osso L, Presta S, Pfanner C, Rossi A, Masala I. et al .
Platelet [3H] paroxetine binding in patients with OCD-related disorders.
Psychiatry Research.
1999;
89
223-228
-
25
Grant J E, Kim S W.
An open-label study of naltrexone in the treatment of kleptomania.
J Clin Psychiatry.
2002;
63
349-356
-
26
Durst R, Katz G, Teitelbaum A, Zislin J, Dannon P N.
Kleptomania-diagnosis and treatment options.
CNS Drugs.
2001;
15
185-195
-
27
Fishbain D A.
Kleptomanic behavior response to perphenazine-amitriptylin hcl combination.
Canadian Journal of psychiatry.
1988;
33 (3)
241-242
-
28
Mc Elroy S, Keck P E, Pope H G, Hudson J I.
Pharmacological treatment of kleptomania and bulimia nervosa.
J Clin Psychopharmacol.
1989;
9
358-360
-
29
Kraus J E.
Treatment of kleptomania with paroxetine.
J Clin Psychiatry.
1999;
60
793
-
30
Lepkifker E, Dannon P N, Reuven Z, Iancu I, Horesh N, Kotler M.
The treatment of kleptomania with serotonin reuptake inhibitors.
Clinical Neuropharmacology.
1999;
22
40-43
-
31
Chong S A, Low B L.
Treatment of kleptomania with fluvoxamine.
Acta Psychiatr Scand.
1996;
93
314-315
-
32
Burstein A.
Fluoxetine-lithium treatment for kleptomania.
J Clin Psychiatry.
1992;
53
28-29
-
33
Feeney D J, Klykylo W M.
Treatment for kleptomania.
J Am Acad Child Adolesc Psychiatry.
1997;
36
723-724
-
34
Durst R, Katz G, Knobler H Y.
Buspirone augmentation of fluvoxamine in the treatment of kleptomania.
J Nerv Ment Dis.
1997;
185
586-588
-
35
Kmetz G F, Mc Elroy S, Collins D J.
Response of kleptomania and mixed mania to valproate.
Am J Psychiatry.
1997;
154
580-581
-
36
Kindler S, Dannon P N, Iancu I, Sasson Y, Zohar J.
Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors.
Clinical Neuropharmacology.
1997;
20
126-129
-
37
Rocha F L, Rocha M E.
Kleptomania, mood disorder and lithium.
Arq Neuropsiquiatr.
1992;
50 (4)
543-546
-
38
Litten R Z, Allen J P.
Medications for alcohol, illicit drug, and tobacco dependence.
J Subst Abuse Treatment.
1999;
16
105-112
-
39
Dannon P N, Iancu I, Grunhaus L.
Naltrexone treatment in kleptomanic patients.
Hum Psychopharmacol Clin Exp.
1999;
14
583-585
Dr. Ralf Kozian
Landesklinik Brandenburg
Anton-Saefkow-Allee 2
14772 Brandenburg
